3Tosoni A, Franceschi E, Errnani M, et al. Temozolomide three weeks on and one week off as first line therapy for patients with re- current or progressive low grade gliomas. J Neurooncol, 2008,89 (2) : 179- 185.
4Tang Y, Luo D, Rong X, et al. Psychological disorders, cognitive dysfunction and quality of life innasopharyngeal carcinoma patients with radiation-- induced brain injury. PLoS One, 2012,7 (6) : 365 -369.
5Semionov V, Singer Y, Shvartzman P. Prevalence and manage- ment of symptoms during the last month of life. Isr Med Assoe J, 2012,14(2) :96-99.
6MEMON M A,SHIWANI M H,ANWER S. Carcinoma of the am-pulla of Vater: results of surgical treatment of a single center[ J].Hepatogastroenterology, 2004,51 .59) : 1275 - 1277.
7AARONSON N K,AHMEDZAI S’ BERGMAN B, et al. The Europe-an Organization for Research and Treatment of Cancer QLQ - C30: aquality of life instrument for use in international clinical trials in on-cology [J]. J Natl Cancer Inst, 1993, 85(5): 365 -376.
